Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity

Rashmi Kademadkal Javaraiah; Chaya Manoranjini David; J. Namitha; Ritu Tiwari; Prabhavati Benakanal

doi:10.1055/s-0040-1721174

South Asian Journal of Cancer, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · South Asian J Cancer 2020; 9(02): 093-098
DOI: 10.1055/s-0040-1721174

Original Article: Head and Neck Cancer

Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity

Rashmi Kademadkal Javaraiah

¹Department of Dentistry, Kanva Sri Sai Hospital, Bengaluru, Karnataka, India

,

Chaya Manoranjini David

²Department of Oral Medicine and Maxillofacial Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India

,

J. Namitha

²Department of Oral Medicine and Maxillofacial Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India

,

Ritu Tiwari

²Department of Oral Medicine and Maxillofacial Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India

,

Prabhavati Benakanal

³Department of Oral Medicine and Maxillofacial Radiology, Sharavathi Dental College, Shimoga, Karnataka, India

› Institutsangaben

Abstract

Background Oral squamous cell carcinoma (OSCC) is a deadly disease that develops in a multistage process and is often preceded by oral potentially malignant disorders (PMDs), of which many are caused by tobacco usage. It is associated with a shift from an aerobic to anaerobic glycolytic pathway, and hence an increase in lactate dehydrogenase (LDH) levels is seen. The objective of this study was to estimate and correlate the level of salivary LDH in healthy individuals with tobacco users (with or without PMDs).

Methods A total of 78 patients were selected from the Department of Oral Medicine and Radiology, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India, and were divided into three groups of 26 patients each, namely controls, tobacco users without PMD, and tobacco users with PMD. A total of 1 mL of unstimulated saliva was collected from each patient using the spit method. Sample was subjected to centrifugation at 2,500 rpm, and salivary LDH was quantified by a standard kit (LDH-P kit, DIALAB, Neudorf, Austria) using an autoanalyzer.

Results There was a statistically significant (p < 0.001) gradual increase in the level of LDH in controls (267 ± 27.64 U/L), tobacco users without PMD (391 ± 80.53 U/L), and tobacco users with PMD (706.1 ± 199 U/L). Increase in the LDH level was also noted with increased duration and frequency of the habit.

Conclusion LDH can potentially be used as a promising biomarker in the very early stages of progression toward oral cancer caused by tobacco use.

Keywords

lactate dehydrogenase - oral cancer - prognosis - saliva - tobacco

Volltext

Referenzen

References
1 Prabhu SR, Johnson NW, Daftary DK. Oral Diseases in the Tropics. 1st ed. New York, NY: Oxford University Press; 1992
2 Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 1999; 85 (05) 1018-1025
3 Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94 (02) 153-156
4 Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37 (01) 1-10
5 Preeti S, Raut DK. Prevalence and pattern of tobacco consumption in India. Int Res J Soc Sci 2012; 1: 36-43
6 Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol 2011; 3: 33
7 Mohan M, Jagannathan N. Oral field cancerization: an update on current concepts. Oncol Rev 2014; 8 (01) 244
8 Rajkumar K, Kumar AR, Ramyamalini V, Nandhini G, Kumar DT, Ashwini BK. Estimation of serological and salivary biomarkers in patients with oral squamous cell carcinoma, premalignant lesions and conditions. SRM Univ J Dent Sci 2010; 1: 14-19
9 Shpitzer T, Hamzany Y, Bahar G. et al. Salivary analysis of oral cancer biomarkers. Br J Cancer 2009; 101 (07) 1194-1198
10 Merza KS, Alaaraji SB, Abdullah BH. Comparative study on lactate dehydrogenase and immunoglobulins in serum and saliva of acute leukemia and oral squamous cell carcinoma patients. Iraqi J Sci 2010; 51: 262-270
11 De La Peña VA, Diz Dios P, Tojo Sierra R. Relationship between lactate dehydrogenase activity in saliva and oral health status. Arch Oral Biol 2007; 52 (10) 911-915
12 Recommendationsof the German Society for Clinical Chemistry. Standardisation of methods for the estimation of enzyme activities in biological fluids. Experimental basis for the optimized standard conditions. Z Klin Chem Klin Biochem 1972; 10 (06) 281-291
13 Agrawal K, Rajderkar SS, Tuljapurkar V. Tobacco related cancers at a tertiary care hospital in Western India. Health Renaiss 2013; 11: 43-46
14 Silverman Jr S, Gorsky M. Epidemiologic and demographic update in oral cancer: California and national data–1973 to 1985. J Am Dent Assoc 1990; 120 (05) 495-499
15 Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people–a comprehensive literature review. Oral Oncol 2001; 37 (05) 401-418
16 International Institute for Population Sciences, Mumbai and Ministry of Health and Family Welfare, Government of India. Global Adult Tobacco Survey India (GATS INDIA); 2009–2010. Available at: https://www.who.int/tobacco/surveillance/survey/gats/gats_india_report.pdf?ua=1
17 Shah FD, Begum R, Vajaria BN. et al. A review on salivary genomics and proteomics biomarkers in oral cancer. Indian J Clin Biochem 2011; 26 (04) 326-334
18 Pereira T, Shetty S, Pereira S. Estimation of serum lactate dehydrogenase level in patients with oral premalignant lesions/conditions and oral squamous cell carcinoma: a clinicopathological study. J Cancer Res Ther 2015; 11 (01) 78-82
19 Nagler RM, Klein I, Reznick AZ. The interaction between saliva and cigarette smoke and its devastating biological effects as related to oral cancer [in Hebrew]. Harefuah 2001; 140 (07) 614-618, 677
20 Todorovic T, Dozic I, Vicente-Barrero M. et al. Salivary enzymes and periodontal disease. Med Oral Patol Oral Cir Bucal 2006; 11 (02) E115-E119
21 Dabra S, China K, Kaushik A. Salivary enzymes as diagnostic markers for detection of gingival/periodontal disease and their correlation with the severity of the disease. J Indian Soc Periodontol 2012; 16 (03) 358-364
22 Shetty SR, Chadha R, Babu S, Kumari S, Bhat S, Achalli S. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: a biochemical and clinicopathological study. J Cancer Res Ther 2012; 8 (08) (Suppl. 01) S123-S125
23 Murray RK, Granner DK, Mayes PA. Harper’s Illustrated Biochemistry. 26th ed. New York, NY: Lange Medical Publications/McGraw-Hill; 2003
24 Centers for Disease Control and Prevention. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2010
25 Baric JM, Alman JE, Feldman RS, Chauncey HH. Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surg Oral Med Oral Pathol 1982; 54 (04) 424-429